you are here: HomeNewsBusiness

Buy Lupin; target of Rs 1350: Sharekhan

Sharekhan is bullish on Lupin has recommended buy rating on the stock with a target price of Rs 1350 in its research report dated January 29, 2021.

February 08, 2021 / 04:07 PM IST


  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Lupin

Q3FY2021 was a healthy quarter for the company and adjusting for one offs the earnings are ahead of estimates. US business is on a strong footing to grow, backed by better-than-expected ramp up of its respiratory product, gAlbuterol and new launches, while India business is expected to improve backed by strong growth in chronics while improving patient footfalls point at pick up in the acute therapy. Focus on cost-control measures and rationalization coupled with benefits of operating leverage and high share of new launches to drive OPM expansion.


We retain Buy recommendation on Lupin Limited (Lupin) with an unchanged PT of RS 1350.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Feb 8, 2021 04:07 pm

stay updated

Get Daily News on your Browser